NM_016239.4(MYO15A):c.6337A>T (p.Ile2113Phe) AND Nonsyndromic genetic hearing loss
- Germline classification:
- Likely pathogenic (1 submission)
- Last evaluated:
- Jul 17, 2024
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV002228014.2
Allele description [Variation Report for NM_016239.4(MYO15A):c.6337A>T (p.Ile2113Phe)]
NM_016239.4(MYO15A):c.6337A>T (p.Ile2113Phe)
Condition(s)
-
PREDICTED: Homo sapiens phospholipid phosphatase 4 (PLPP4), transcript variant X...
PREDICTED: Homo sapiens phospholipid phosphatase 4 (PLPP4), transcript variant X8, mRNAgi|2217275816|ref|XM_017015822.2|Nucleotide
-
Homo sapiens phospholipid phosphatase 4 (PLPP4), transcript variant 4, mRNA
Homo sapiens phospholipid phosphatase 4 (PLPP4), transcript variant 4, mRNAgi|1889500745|ref|NM_001318168.2|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Oct 13, 2024